DK0458823T3 - Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridiner - Google Patents
Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridinerInfo
- Publication number
- DK0458823T3 DK0458823T3 DK90903015.7T DK90903015T DK0458823T3 DK 0458823 T3 DK0458823 T3 DK 0458823T3 DK 90903015 T DK90903015 T DK 90903015T DK 0458823 T3 DK0458823 T3 DK 0458823T3
- Authority
- DK
- Denmark
- Prior art keywords
- dihydropyridines
- enantiomerically pure
- dihydropridines
- polysubstituted
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8919477A IT1230752B (it) | 1989-02-17 | 1989-02-17 | Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0458823T3 true DK0458823T3 (da) | 1994-02-21 |
Family
ID=11158352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90903015.7T DK0458823T3 (da) | 1989-02-17 | 1990-02-15 | Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridiner |
Country Status (17)
Country | Link |
---|---|
US (1) | US5245039A (ko) |
EP (2) | EP0383320A1 (ko) |
JP (1) | JPH04505610A (ko) |
KR (1) | KR0155557B1 (ko) |
AT (1) | ATE95813T1 (ko) |
AU (1) | AU630928B2 (ko) |
CA (1) | CA2047741A1 (ko) |
DE (1) | DE69003936T2 (ko) |
DK (1) | DK0458823T3 (ko) |
ES (1) | ES2060144T3 (ko) |
FI (1) | FI95371C (ko) |
HU (1) | HUT62270A (ko) |
IE (1) | IE66498B1 (ko) |
IT (1) | IT1230752B (ko) |
NO (1) | NO177186C (ko) |
RU (1) | RU2069658C1 (ko) |
WO (1) | WO1990009376A1 (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571827A (en) * | 1990-03-13 | 1996-11-05 | Sepracor Inc. | Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
US5834496A (en) * | 1991-12-02 | 1998-11-10 | Sepracor, Inc. | Methods for treating hypertension using optically pure S(-) felodipine |
JPH07501551A (ja) * | 1991-12-02 | 1995-02-16 | セプラコア,インコーポレーテッド | 光学的に純粋なs(−)フェロジピンを用いる,高血圧,狭心症および他の疾患を治療するための方法および組成物 |
ES2055653B1 (es) * | 1992-09-22 | 1995-03-01 | Elmuquimica Farm Sl | Procedimiento de obtencion del 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isopropil-5-(2-metoxi)etil. |
ES2055652B1 (es) * | 1992-09-22 | 1995-03-01 | Elmuquimica Farm Sl | Procedimiento de obtencion de 2,6-dimetil-4-(2,3-diclorofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil. |
ES2055654B1 (es) * | 1992-09-22 | 1995-03-01 | Elmuquimica Farm Sl | Procedimiento de obtencion de 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil. |
ES2055655B1 (es) * | 1992-09-22 | 1995-03-01 | Elmuquimica Farm Sl | Procedimiento de obtencion de 2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isobutil-5-metil. |
GB9405833D0 (en) * | 1994-03-24 | 1994-05-11 | Pfizer Ltd | Separation of the enantiomers of amlodipine |
FR2719585B1 (fr) * | 1994-05-05 | 1996-08-02 | Lafon Labor | Procédé d'obtention de 1,4-dihydropyridines optiquement pures. |
US5554621A (en) * | 1995-06-07 | 1996-09-10 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives |
ITMI20012434A1 (it) | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3447169A1 (de) * | 1984-12-22 | 1986-07-03 | Bayer Ag, 5090 Leverkusen | Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
HU199796B (en) * | 1985-08-06 | 1990-03-28 | Boehringer Biochemia Srl | Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds |
EP0225175A3 (en) * | 1985-11-28 | 1988-12-28 | FISONS plc | Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof |
US4920225A (en) * | 1986-12-22 | 1990-04-24 | Laboratoires Syntex S.A. | Resolution of 1,4-dihydropyridine derivatives |
WO1988007531A1 (en) * | 1987-03-27 | 1988-10-06 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New optically active compounds |
US4994461A (en) * | 1987-03-27 | 1991-02-19 | Byk Gulden Lomberg Chemische Fabrik Gmbh | 1,4-dihydropyridine enantiomers |
-
1989
- 1989-02-17 IT IT8919477A patent/IT1230752B/it active
-
1990
- 1990-02-15 DK DK90903015.7T patent/DK0458823T3/da active
- 1990-02-15 AU AU50904/90A patent/AU630928B2/en not_active Ceased
- 1990-02-15 AT AT90903015T patent/ATE95813T1/de not_active IP Right Cessation
- 1990-02-15 KR KR1019900702275A patent/KR0155557B1/ko not_active IP Right Cessation
- 1990-02-15 EP EP90102951A patent/EP0383320A1/en not_active Withdrawn
- 1990-02-15 CA CA002047741A patent/CA2047741A1/en not_active Abandoned
- 1990-02-15 DE DE90903015T patent/DE69003936T2/de not_active Expired - Fee Related
- 1990-02-15 JP JP2503175A patent/JPH04505610A/ja active Pending
- 1990-02-15 EP EP90903015A patent/EP0458823B1/en not_active Expired - Lifetime
- 1990-02-15 HU HU901962A patent/HUT62270A/hu unknown
- 1990-02-15 RU SU905001680A patent/RU2069658C1/ru active
- 1990-02-15 US US07/743,415 patent/US5245039A/en not_active Expired - Fee Related
- 1990-02-15 ES ES90903015T patent/ES2060144T3/es not_active Expired - Lifetime
- 1990-02-15 WO PCT/EP1990/000243 patent/WO1990009376A1/en active IP Right Grant
- 1990-02-16 IE IE58490A patent/IE66498B1/en not_active IP Right Cessation
-
1991
- 1991-08-15 FI FI913861A patent/FI95371C/fi not_active IP Right Cessation
- 1991-08-15 NO NO913188A patent/NO177186C/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU630928B2 (en) | 1992-11-12 |
DE69003936D1 (de) | 1993-11-18 |
HUT62270A (en) | 1993-04-28 |
NO913188D0 (no) | 1991-08-15 |
EP0383320A1 (en) | 1990-08-22 |
IT1230752B (it) | 1991-10-29 |
NO177186C (no) | 1995-08-02 |
KR0155557B1 (ko) | 1998-11-16 |
FI95371B (fi) | 1995-10-13 |
DE69003936T2 (de) | 1994-03-31 |
IE900584L (en) | 1990-08-17 |
FI913861A0 (fi) | 1991-08-15 |
ATE95813T1 (de) | 1993-10-15 |
IT8919477A0 (it) | 1989-02-17 |
EP0458823B1 (en) | 1993-10-13 |
NO913188L (no) | 1991-08-15 |
CA2047741A1 (en) | 1990-08-18 |
IE66498B1 (en) | 1996-01-10 |
ES2060144T3 (es) | 1994-11-16 |
WO1990009376A1 (en) | 1990-08-23 |
JPH04505610A (ja) | 1992-10-01 |
RU2069658C1 (ru) | 1996-11-27 |
EP0458823A1 (en) | 1991-12-04 |
KR910700234A (ko) | 1991-03-14 |
AU5090490A (en) | 1990-09-05 |
FI95371C (fi) | 1996-01-25 |
US5245039A (en) | 1993-09-14 |
NO177186B (no) | 1995-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0458823T3 (da) | Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridiner | |
NO20083728L (no) | Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid | |
DK369284A (da) | Aprotininhomologe med andre aminosyrer i stilling 15 i stedet for lysin, fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemiddel | |
DE69311000D1 (de) | Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 1-Halogen-2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Derivaten | |
IT7823679A0 (it) | Processo enzimatico-microbiologico per la produzione di amminoacidi otticamente attivi a partire da idantoine e/o carbamil-derivati racemi. | |
DE68916754D1 (de) | Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure. | |
DK0535939T3 (da) | Fremgangsmåde til fremstilling af omega 9-type polyumættet fedtsyre | |
PT92603A (pt) | Processo de producao de factor de crescimento transformante, quimerico,beta | |
DE69009237D1 (de) | Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure. | |
NO177500C (no) | Fremgangsmåte til fremstilling av en terapeutisk aktiv hirudinvariant | |
ES2090075T3 (es) | Procedimiento para la preparacion de diastereoisomeros opticamente puros de compuestos de tetrahidrofolato. | |
DE69007599D1 (de) | Verfahren zur Racemisierung optisch aktiver Carbonsäureester. | |
PT91006A (pt) | Processo para a preparacao de um novo sal de estroncio | |
DK144417C (da) | Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive alfa-(3,4-dimethoxyphenethylaminomethyl)-2-alkoxybenzylalkoholer eller farmaceutisk anvendelige syreadditionssalte deraf | |
ATA302677A (de) | Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro/isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzen | |
DE3569725D1 (en) | A method for the optical purification of an optically active 2,2-dimethylcyclopropanecarboxylic acid amide | |
AT375940B (de) | Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze | |
DE69033833D1 (de) | Verfahren zur Herstellung von Butantetracarbonsäure | |
DK149592C (da) | Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive1,1-disubstituerede octahydro-indolo(2,3-a)quinoliziner eller farmaceutisk acceptable syreadditionssalte deraf | |
ATA174887A (de) | Verfahren zur herstellung von hydroximinsaeuren von 7-oxabicycloheptansubstituierten prostaglandinether- und -thioetheranalogen und von deren stereoisomeren und pharmazeutisch annehmbaren salzen | |
DE68920265D1 (de) | Verfahren zur Enantiomerentrennung von Cis-3-amino-4-[2-(2-furyl)vinyl]-1-methoxycarbonylmethyl-azetidin-2-on und deren Di-p-Toluoyl-Weinsäuresalze. | |
ATA18878A (de) | Verfahren zur herstellung von (1,1-dithienyl- -(3-propen-(1)-yl-(3))-(1-phenyl-1-hydroxyproyl -(2))-amin und dessen saeureadditionssalzen und optisch aktiven isomeren | |
ES2089327T3 (es) | Procedimiento e intermediarios para la preparacion de un agente antivirico que contiene un grupo ciclobutilo. | |
DE68928788D1 (de) | Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten | |
DE3851942D1 (de) | Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure. |